Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 18, 2026 13:45 ET | Source: Cosmos Health Inc.

Cosmos Health Continues UK Retail Expansion for C-Scrub; Now Available at Superdrug, the UK’s Second-Largest Beauty and Health Retailer

Cosmos Health's C-Scrub wash is now available through Superdrug, the UK’s second-largest beauty and health retailer.
February 18, 2026 10:17 ET | Source: Cosmos Health Inc.

Cosmos Health Announces Growing Momentum for C-Scrub in the United Kingdom; Now Available at Tesco, the UK’s Largest Retailer

Cosmos Health's antimicrobial skin cleanser C-Scrub is now available at Tesco, the UK’s largest retailer with almost 30% market share.
February 17, 2026 11:25 ET | Source: Cosmos Health Inc.

Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026

CHICAGO, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced its...
February 11, 2026 12:10 ET | Source: Cosmos Health Inc.

Cosmos Health Expands Digital Assets Program with $500,000 Bitcoin Purchase, Bringing Total Cryptocurrency Investments to $2.5 Million; Evaluates Inclusion of Other Select Cryptocurrencies

CHICAGO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the...
January 14, 2026 11:25 ET | Source: Cosmos Health Inc.

Cosmos Health Announces Initiation of Analyst Coverage with $4.50 Valuation by Zacks Small-Cap Research

CHICAGO, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that...
January 05, 2026 09:30 ET | Source: Cosmos Health Inc.

Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units

Cosmos Health signs a manufacturing agreement with Lybitec for PathMuscle, targeting expected production volumes of over 1.2 million units in five years.
December 03, 2025 12:20 ET | Source: Cosmos Health Inc.

Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets

Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets
December 02, 2025 12:15 ET | Source: Cosmos Health Inc.

Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases

Cosmos Health CEO Greg Siokas increases total ownership to 6,459,985 shares.
November 17, 2025 09:15 ET | Source: Cosmos Health Inc.

Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M

Cosmos Health reports record Q3 2025 Results with all-time high revenue, gross profit and gross margin. Revenue up 38%, gross profit up 116%.
October 21, 2025 12:10 ET | Source: Cosmos Health Inc.

Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million

CHICAGO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it...